 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- || SR419 / Shanghai SIMR Biotech
Enrollment closed, Trial completion date: To Evaluate the Efficacy and Safety of SR419 in Patients With Postherpetic Neuralgia (PHN) (clinicaltrials.gov) - Nov 30, 2022
P2, N=83, Active, not recruiting, Sponsor: Shanghai SIMR Biotechnology Co., Ltd.
Recruiting --> Active, not recruiting | Trial completion date: Jul 2023 --> Jan 2023
- || SR419 / Shanghai SIMR Biotech
Trial completion, Trial completion date, Trial primary completion date: A Phase 1b Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of SR419 (clinicaltrials.gov) - Aug 5, 2022
P1b, N=24, Completed, Sponsor: SIMR (Australia) Biotech Pty Ltd.
Recruiting --> Active, not recruiting | Trial completion date: Jul 2023 --> Jan 2023 Recruiting --> Completed | Trial completion date: Dec 2021 --> Jul 2022 | Trial primary completion date: Dec 2021 --> May 2022
- | SR419 / Shanghai SIMR Biotech
Trial completion date: The Pharmacokinetics (PK), Safety, Tolerability of SR419 in Healthy Volunteers (clinicaltrials.gov) - Aug 3, 2022
P1, N=40, Completed, Sponsor: Shanghai SIMRD Biotechnology Co., Ltd.
Recruiting --> Completed | Trial completion date: Dec 2021 --> Jul 2022 | Trial primary completion date: Dec 2021 --> May 2022 Trial completion date: Dec 2021 --> May 2022
- ||| SR419 / Shanghai SIMR Biotech
Enrollment open: To Evaluate the Efficacy and Safety of SR419 in Patients With Postherpetic Neuralgia (PHN) (clinicaltrials.gov) - May 31, 2022
P2, N=82, Recruiting, Sponsor: Shanghai SIMR Biotechnology Co., Ltd.
Trial completion date: Dec 2021 --> May 2022 Not yet recruiting --> Recruiting
- |||| SR419 / Shanghai SIMR Biotech
New P2 trial: To Evaluate the Efficacy and Safety of SR419 in Patients With Postherpetic Neuralgia (PHN) (clinicaltrials.gov) - May 3, 2022
P2, N=82, Not yet recruiting, Sponsor: Shanghai SIMR Biotechnology Co., Ltd.
- || SR419 / Shanghai SIMR Biotech
Trial completion: The Pharmacokinetics (PK), Safety, Tolerability of SR419 in Healthy Volunteers (clinicaltrials.gov) - Mar 2, 2022
P1, N=40, Completed, Sponsor: Shanghai SIMRD Biotechnology Co., Ltd.
Not yet recruiting --> Recruiting Recruiting --> Completed
- || SR419 / Shanghai SIMR Biotech
Enrollment open: The Pharmacokinetics (PK), Safety, Tolerability of SR419 in Healthy Volunteers (clinicaltrials.gov) - Aug 30, 2021
P1, N=32, Recruiting, Sponsor: Shanghai SIMRD Biotechnology Co., Ltd.
Recruiting --> Completed Not yet recruiting --> Recruiting
- | SR419 / Shanghai SIMR Biotech
New P1 trial: The Pharmacokinetics (PK), Safety, Tolerability of SR419 in Healthy Volunteers (clinicaltrials.gov) - Aug 18, 2021
P1, N=32, Not yet recruiting, Sponsor: Shanghai SIMRD Biotechnology Co., Ltd.
- | SR419 / Shanghai SIMR Biotech
Trial completion date, Trial primary completion date: A Phase 1b Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of SR419 (clinicaltrials.gov) - Aug 18, 2021
P1b, N=24, Recruiting, Sponsor: SIMR (Australia) Biotech Pty Ltd.
Not yet recruiting --> Recruiting Trial completion date: Jun 2021 --> Dec 2021 | Trial primary completion date: Jun 2021 --> Dec 2021
- || SR419 / Shanghai SIMR Biotech
Trial completion: A Study to Assess the Pharmacokinetics and Food Effect of SR419 in Healthy Subjects (clinicaltrials.gov) - Mar 24, 2021
P1, N=24, Completed, Sponsor: SIMR (Australia) Biotech Pty Ltd
Trial completion date: Jun 2021 --> Dec 2021 | Trial primary completion date: Jun 2021 --> Dec 2021 Recruiting --> Completed
- || SR419 / Shanghai SIMR Biotech
Enrollment open: A Study to Assess the Pharmacokinetics and Food Effect of SR419 in Healthy Subjects (clinicaltrials.gov) - Mar 1, 2021
P1, N=24, Recruiting, Sponsor: SIMR (Australia) Biotech Pty Ltd
Recruiting --> Completed Not yet recruiting --> Recruiting
- || SR419 / Shanghai SIMR Biotech
New P1 trial: A Study to Assess the Pharmacokinetics and Food Effect of SR419 in Healthy Subjects (clinicaltrials.gov) - Jan 11, 2021
P1, N=24, Not yet recruiting, Sponsor: SIMR (Australia) Biotech Pty Ltd
- | SR419 / Shanghai SIMR Biotech
Trial completion date, Trial primary completion date: A Phase 1b Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of SR419 (clinicaltrials.gov) - Dec 3, 2020
P1b, N=24, Recruiting, Sponsor: SIMR (Australia) Biotech Pty Ltd
Not yet recruiting --> Recruiting Trial completion date: Jan 2021 --> Jun 2021 | Trial primary completion date: Jan 2021 --> Jun 2021
- || SR419 / Shanghai SIMR Biotech
Enrollment open: A Phase 1b Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of SR419 (clinicaltrials.gov) - Oct 13, 2020
P1b, N=24, Recruiting, Sponsor: SIMR (Australia) Biotech Pty Ltd
Trial completion date: Jan 2021 --> Jun 2021 | Trial primary completion date: Jan 2021 --> Jun 2021 Not yet recruiting --> Recruiting
- || SR419 / Shanghai SIMR Biotech
New P1 trial: A Phase 1b Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of SR419 (clinicaltrials.gov) - Aug 7, 2020
P1b, N=24, Not yet recruiting, Sponsor: SIMR (Australia) Biotech Pty Ltd
- ||| SR419 / Shanghai SIMR Biotech
Trial completion: The Safety, Tolerability, Pharmacokinetics(PK) of SR419 in Healthy Volunteers (clinicaltrials.gov) - Dec 12, 2019
P1, N=64, Completed, Sponsor: SIMR (Australia) Biotech Pty Ltd
Not yet recruiting --> Recruiting Recruiting --> Completed
- | SR419 / Shanghai SIMR Biotech
Enrollment open: The Safety, Tolerability, Pharmacokinetics(PK) of SR419 in Healthy Volunteers (clinicaltrials.gov) - Jul 29, 2019
P1, N=84, Recruiting, Sponsor: SIMR (Australia) Biotech Pty Ltd
Recruiting --> Completed Not yet recruiting --> Recruiting
- | SR419 / Shanghai SIMR Biotech
New P1 trial: The Safety, Tolerability, Pharmacokinetics(PK) of SR419 in Healthy Volunteers (clinicaltrials.gov) - Jul 15, 2019
P1, N=84, Not yet recruiting, Sponsor: SIMR (Australia) Biotech Pty Ltd